HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
HR3910, Dillon's Law; HR5749, Family Asthma Act
HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
HR 3935, Securing Growth and Robust Leadership in American Aviation Act, Epinephrine in Emergency Medical Kits on airlines; S no bill number, Federal Aviation Administration (FAA) Reauthorization Act, Epinephrine in Emergency Medical Kits on airlines.
Duration: March 8, 2018
to
January 1, 2024
General Issues: Health Issues , Budget/Appropriations , Aviation/Aircraft/Airlines , Medical/Disease Research/Clinical Labs , Education
Spending: about $460,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives, Transportation - Dept of (DOT), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. terminated an engagement in which they represented Asthma & Allergy Foundation of America on April 19.
Original Filing: 301566888.xml
4th Quarter, 2023
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 26.
Original Filing: 301542059.xml
Lobbying Issues
HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
HR3910, Dillon's Law; HR5749, Family Asthma Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3935, Securing Growth and Robust Leadership in American Aviation Act, Epinephrine in Emergency Medical Kits on airlines; S no bill number, Federal Aviation Administration (FAA) Reauthorization Act, Epinephrine in Emergency Medical Kits on airlines.
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
3rd Quarter, 2023
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 19, 2023.
Original Filing: 301508112.xml
Lobbying Issues
HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
HR3910, Dillon's Law; HR5749, Family Asthma Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR5894/S 2624,FY24 Labor HHS Education Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3935, Securing Growth and Robust Leadership in American Aviation Act, Epinephrine in Emergency Medical Kits on airlines; S no bill number, Federal Aviation Administration (FAA) Reauthorization Act, Epinephrine in Emergency Medical Kits on airlines.
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
2nd Quarter, 2023
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 19, 2023.
Original Filing: 301482530.xml
Lobbying Issues
FY24 Labor HHS Education Act, funding for the National Asthma Control Program
HR 3910, Dillon's Law
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY24 Labor HHS Education Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 3935, Securing Growth and Robust Leadership in American Aviation Act, Epinephrine in Emergency Medical Kits on airlines; S no bill number, Federal Aviation Administration (FAA) Reauthorization Act, Epinephrine in Emergency Medical Kits on airlines.
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
1st Quarter, 2023
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on April 17, 2023.
Original Filing: 301453009.xml
Lobbying Issues
FY24 Labor HHS Education Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
Lobbying Issues
Epinephrine in Emergency Medical Kits on airlines
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
4th Quarter, 2022
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 17, 2023.
Original Filing: 301429421.xml
Lobbying Issues
HR 8295/S no bill #, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program; HR 7055 Family Asthma Act; HR 2617/PL 117-328, Consolidated Appropriations Act, fiscal year 2023, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 8295/ S. no bill #, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program; HR 2617/PL 117-328, Consolidated Appropriations Act, fiscal year 2023, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413499.xml
Lobbying Issues
HR 8295/S no bill #, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program; HR 7055 Family Asthma Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 8295/ S. no bill #, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program;
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 18, 2022.
Original Filing: 301383492.xml
Lobbying Issues
HR 8295, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program; HR 7055 Family Asthma Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 8295, FY23 Labor-HHS-Education Act; funding for the CDC National Asthma Control Program;
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301368524.xml
Lobbying Issues
FY22/FY23 Labor-HHS-Education Act
Funding for the CDC National Asthma Control Program
HR 2471, Consolidated Appropriations Act for fiscal year 2022
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
1st Quarter, 2022
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. amended a lobbying report for representation of Asthma & Allergy Foundation of America in Q12022 on April 20, 2022.
Original Filing: 301368575.xml
Lobbying Issues
FY22/FY23 Labor-HHS-Education Act
Funding for the CDC National Asthma Control Program
HR 2471, Consolidated Appropriations Act for fiscal year 2022
HR 7055, Family Asthma Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY22/FY23 Labor-HHS-Education Act
Funding for the CDC National Asthma Control Program
HR 2471, Consolidated Appropriations Act for fiscal year 2022
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 20, 2022.
Original Filing: 301336611.xml
Lobbying Issues
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
3rd Quarter, 2021
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 19, 2021.
Original Filing: 301305841.xml
Lobbying Issues
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Appropriations
2nd Quarter, 2021
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 19, 2021.
Original Filing: 301282321.xml
Lobbying Issues
HR 1202/S 578, Food Allergy Safety, Treatment, Education and Research (FASTER) Act
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on April 16, 2021.
Original Filing: 301254530.xml
Lobbying Issues
HR 1202/S 578, Food Allergy Safety, Treatment, Education and Research (FASTER) Act
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY22 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 13, 2021.
Original Filing: 301230722.xml
Lobbying Issues
H.R. 2468, School-Based Allergies and Asthma Program Management Act
H.R. 5230, Family Asthma Act
H.R. 2117/S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
HR 133, PL 116-260, FY 21 Omnibus and COVID Relief an Response Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
HR 133, PL 116-260, FY 21 Omnibus and COVID Relief an Response Act, funding for the National Asthma Control Program
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216148.xml
Lobbying Issues
H.R. 2468, School-Based Allergies and Asthma Program Management Act
H.R. 5230, Family Asthma Act
H.R. 2117/S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 17, 2020.
Original Filing: 301191074.xml
Lobbying Issues
H.R. 2468, School-Based Allergies and Asthma Program Management Act
H.R. 5230, Family Asthma Act
H.R. 2117/S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Access to Epinephrine Auto-Injectors
Shortages of Albuterol Inhalers
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on April 15, 2020.
Original Filing: 301167032.xml
Lobbying Issues
H.R. 2468, School-Based Allergies and Asthma Program Management Act
H.R. 5230, Family Asthma Act
H.R. 2117/S. 3451, Food Allergy Safety, Treatment, Education, and Research (FASTER) Act
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Access to Epinephrine Auto-Injectors
Shortages of Albuterol Inhalers
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY21 Labor-HHS-Education Act, funding for the CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 15, 2020.
Original Filing: 301106350.xml
Lobbying Issues
HR 2468, Allergies and Asthma Program Management Act
FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
HR 2740 FY20 Labor-HHS-Education Appropriations
CDC National Asthma Control Program
HR 5230, Family Asthma Act
HR 1865, Further Consolidated Appropriations Act, CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
3rd Quarter, 2019
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069039.xml
Lobbying Issues
HR 2468, Allergies and Asthma Program Management Act
FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
HR 2740 FY20 Labor-HHS-Education Appropriations
CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
2nd Quarter, 2019
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 11, 2019.
Original Filing: 301044493.xml
Lobbying Issues
HR 2468, Allergies and Asthma Program Management Act
FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
HR 2740 FY20 Labor-HHS-Education Appropriations
CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
1st Quarter, 2019
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on April 11, 2019.
Original Filing: 301024192.xml
Lobbying Issues
School-Based Respiratory Health Management Act
FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
FY20 Labor-HHS-Education Appropriations, CDC National Asthma Control Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
4th Quarter, 2018
In Q4, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Jan. 18, 2019.
Original Filing: 301007714.xml
Lobbying Issues
HR 2285, School-Based Respiratory Health Management Act
HR 302, FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
Agencies Lobbied
U.S. Senate
Lobbying Issues
S1418, Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
S1318, Air Carrier Access Amendments Act, accommodations by airlines for people with asthma and allergies
HR 302, FAA Reauthorization Act, airline passenger Bill of Rights
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
3rd Quarter, 2018
In Q3, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989142.xml
Lobbying Issues
HR6157/S3159, FY19 Defense, Labor HHS Education Appropriations Act, National Asthma Control Program
HR 2285, School-Based Respiratory Health Management Act
HR 302, FAA Reauthorization Act, airline passenger Bill of Rights
Access to Epinephrine Auto-Injectors
Agencies Lobbied
U.S. Senate
Lobbying Issues
S1418, Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
S1318, Air Carrier Access Amendments Act, accommodations by airlines for people with asthma and allergies
HR 302, FAA Reauthorization Act, airline passenger Bill of Rights
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
2nd Quarter, 2018
In Q2, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America , earning $20,000. The report was filed on July 16, 2018.
Original Filing: 300965241.xml
Lobbying Issues
Labor-HHS-Education Appropriations Act, no HR bill number; S3158, FY 19, National Asthma Control Program
HR 2285, School-Based Respiratory Health Management Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
S1418, Airline Passengers' Bill of Rights Act, accommodations by airlines for people with asthma and allergies
S1318, Air Carrier Access Amendments Act, accommodations by airlines for people with asthma and allergies
Agencies Lobbied
U.S. Senate
Type of Issue
Aviation/Aircraft/Airlines
1st Quarter, 2018
In Q1, CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. lobbied for Asthma & Allergy Foundation of America . The report was filed on April 18, 2018.
Original Filing: 300947804.xml
Lobbying Issues
Labor-HHS-Education Appropriations Act, no bill numbers
National Asthma Control Program
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. filed a lobbying registration on March 13, 2018 to represent Asthma & Allergy Foundation of America, effective March 8, 2018.
Original Filing: 300941445.xml
Issue(s) they said they’d lobby about: Appropriations for National Asthma Control Program at CDC, H.R. 2285, School Based Respiratory Health Management Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...